Ukraine has approved a new sectoral standard for the treatment of breast cancer (MoH order No. 195 of 03.02.2025) and evidence-based clinical guidelines https://www.dec.gov.ua/mtd/rak-molochnoyi-zalozy/
The standard of medical care has been developed to improve early detection of breast cancer through effective screening programs and to unify approaches to diagnosis and treatment, taking into account current international achievements.
Methodological and informational support for the work of the multidisciplinary working group on developing the Standard was provided by specialists of the Medical Care Standardization Department of the Center.
The standard of medical care “Breast cancer” replaces the previous Unified Clinical Protocol of Primary, Secondary (Specialized), Tertiary (Highly Specialized) Medical Care “Breast cancer” of 2015, which was approved by MoH order No. 396 “On approval and implementation of medical technological documents on standardization of medical care for breast cancer”.
It provides updated approaches to organizing medical care for patients with breast cancer, early detection, effective diagnosis, systemic therapy, and follow-up of patients. It is aimed at a comprehensive integrated approach to patient management by oncologists, general practitioners/family doctors, and practical psychologists.
Doctors are also recommended the clinical guidelines “Early Breast Cancer” and “Metastatic Breast Cancer”, which were developed and adapted to the health care system on the basis of the latest scientific developments of the European Society for Medical Oncology (ESMO). They provide a more detailed understanding of the genetic factors that contribute to the development of breast cancer, and recommendations on screening, diagnostic and treatment methods depending on the subtype and severity of the case.
The texts of the new sectoral documents can be found in the MTD Register at the link https://www.dec.gov.ua/mtd/rak-molochnoyi-zalozy/
Breast cancer is one of the most common forms of cancer among women worldwide. It is diagnosed mainly in women over 50 years of age, although about 1 in 5 cases occur before the age of 50. Breast cancer in men is rare and accounts for about 1% of cases. The most important risk factors: genetic predisposition, exposure to estrogens, including long-term hormone replacement therapy, ionizing radiation, low parity, a history of atypical hyperplasia, etc.
